Dr Sarah Jarvis, General Practitioner and Medical Broadcaster, London
Chair of the T2D Talks webinar series alongside several experts
A case-based approach to managing type 2 diabetes in adults with complex comorbidities
Dr Sarah Jarvis and Professor Mike Cummings
Addressing treatment non-adherence in the management of adults with type 2 diabetes
Dr Sarah Jarvis and Hannah Beba
Chronic kidney disease in adult type 2 diabetes: Practical advice for screening, management and referral
Dr Sarah Jarvis and Dr Janaka Karalliedde
Addressing inequalities and socioeconomic factors in adult type 2 diabetes: Strategies to improve treatment outcomes
Dr Sarah Jarvis and Professor Wasim Hanif
Trajenta is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:
monotherapy when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment
in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control
PC-GB-110501 V3 | September 2025
